The Affordable Care Act Conundrum: Facing Reality in America’s Giant Social Experiment

November/December 2013, Vol 6, No 9 - Editorial, Perspectives
Kip Piper, MA, FACHE

President
Health Results Group;
CEO, Medonomics, Washington, DC

Download PDF

The Affordable Care Act (ACA) is the law of the land, but its implementation so far has been fraught with serious problems. The initial launch of www.healthcare.gov was a disaster. It is unclear whether the Centers for Medicare & Medicaid Services (CMS) or the office of the Department of Health and Human Services Secretary told the White House that the October 1 deadline for the launch was not doable or highly risky, or if anyone suggested a delay.

It seems that everyone in the Obama Administration went into a stay-on-message-at-all-costs mode, which is understandable: it is the norm in the federal government. But it comes at the cost of poor public administration. Internally, staff within CMS always knew that the ACA implementation would be problematic. In today’s Washington, optics trump honesty and transparency. It is hard to say how much this culture kept the White House from facing, or even internally admitting, the practical issues or risks involved in the launching of the website and the backroom data functions critical to actual enrollment in coverage. Where do we go from here?

A Giant Social Experiment
The ACA is a giant social experiment with few precedents. It is impossible to predict precisely what will happen next with the implementation of the law, or how consumers and employers will respond in the post-ACA world.

It is easier to predict the behavior of health insurers and providers, as well as the overall impact on them, but this is still complex. Americans and the US media have a short attention span. Change happens rapidly, and the law is so complex, that few people or organizations have the patience to understand even parts of the ACA. The enrollment numbers in the first 3 weeks of December will be critical to assessing how well the federal exchange is working, as well as the response of the public to the repaired website.

The number of new Medicaid enrollees will likely remain higher than new enrollees in the subsidized exchange plans in the first 2 years. We know that this is the case of states that have state-run exchanges, and Medicaid enrollment increases will be especially high in the states with Medicaid expansion; but nationwide, there is every reason to believe that Medicaid enrollment will outpace the subsidized exchange enrollment. In addition to a massive jump in enrollment through expansion eligibility to millions of low-income adults in half of the states, Medicaid rolls will increase in every state from a streamlined eligibility and enrollment process mandated nationwide by the ACA.

Furthermore, Medicaid enrollment is year-round, not tied to an open enrollment period, and an easier, no-cost decision-making process for consumers, unlike the enrollment process in the exchanges. The enrollment in subsidized exchange plans could outpace the rise in Medicaid rolls if and when more small and midsize employers drop their current healthcare coverage. Sign-ups during January through March 2014, the second half of the initial open enrollment period, will be important to watch, when outreach and marketing efforts are expected to restart.

Under the special enrollment rules, many consumers will be able to sign up for exchange coverage after the open enrollment period, which ends on March 31, 2014, if they have a significant change in family or financial circumstances. However, that volume will not be nearly as large or as important as the exchange sign-up during the open enrollment period or the continuous, always-open Medicaid enrollment.

But volume by itself is not enough information to assess the ACA’s success. For that we will need to know, for example, the impact on the uninsured rate, the age and the health risk characteristics of those enrolled, the benefit design choices, the number of people losing individual or employer-sponsored coverage, and the effect of Medicaid expansion and streamlined Medicaid eligibility.

The law is also a moving target as a result of a series of Obama Administration decisions to delay enforcement of key ACA provisions, for a mixture of practical and political reasons. Major provisions of the ACA, including the employer mandate and small employer exchanges in most states, are delayed until 2015, the start of the open enrollment period for 2015 has been shifted until after the November 2014 elections, states are encouraged to temporarily allow short-term renewal of insurance policies outlawed by the ACA, and CMS is proposing changes to how exchange plans are paid.

Overall, most people have not yet experienced the effects, positive and negative, of the ACA. In terms of coverage and costs, the ACA creates a giant game of musical chairs, which has just begun. Every American will be affected by the ACA in some way.

The biggest winners are the uninsured, who are or will be newly covered through Medicaid or through federally subsidized exchange coverage. Some of the losers, including people facing higher premiums, are starting to feel the pain, but the main disadvantages of the ACA are yet to be experienced. The law is all about improving equity through the use of a maze of redistributive mechanisms. It will take time before this plays out.

The short experience with the ACA can only shed light on issues that should have been addressed a long time ago, but for which there was not an interested audience.

Payers’ Perspective
The majority of health insurance companies know that the original strategic reasons for entering the insurance exchange market are still valid, assuming that CMS is able to get the website and the data transfers working soon. Companies that have Medicaid plans are also anxious to see how Medicaid enrollment evolves, and how soon will enrollment problems be resolved. The initial disaster with rollout of the federal exchange complicates payers’ strategy, business planning, and forecasts.

Payers know that they may need to adjust their expectations and future plans to some extent, but they have little information from the federal government, which makes their job difficult. This situation is further exacerbated by the larger unknowns, such as how consumers will react to the new exchange plans, including their costs and choices. While their business dynamics are inherently complex and vary by state, health insurers specializing in the Medicaid market are naturally in a better position under the ACA, given the substantial increase in enrollees.

Facing a double-edged sword of an uncertain payer marketplace and deep payment cuts—to help pay for the cost of ACA—hospitals and health systems are worried. A decrease in the number of uninsured Americans will help trim uncompensated care costs, but it will generally not offset lower reimbursement from Medicare, Medicaid, and the new exchange plans and a shift of patients from higher-paying private plans to lower-paying tax­payer-financed health plans. Insurance companies know that they may need to reconfigure their 2014-2015 budgets to cover more Medicaid patients and fewer members with commercial plan coverage or with exchange-based coverage than was expected.

Hospitals in states that are seeking Medicaid reform waivers—notably, Wisconsin, Iowa, and Pennsylvania—are generally eager to see those get approved and implemented soon, because the waivers would expand access to coverage.

Manufacturers’ Perspective
Pharmaceutical, biotechnology, and medical device companies vary considerably in their understanding of the implications of the ACA. Some companies are fairly well-versed, but others have limited understanding of what it all means. It is harder for drug or device companies than, say, for insurance companies or for large healthcare providers, to understand the potential implications of the ACA on them, because the effects of the ACA, although significant, are indirect and nonlinear. Indirect, because the ACA and changes in the marketplace are fundamentally transforming the economics, incentives, and decision-making of coverage, payment, and care delivery. Nonlinear, because, in this time of unprecedented, polygonal change, the new policy and market spheres appear chaotic, unpredictable, or counter­intuitive, and therefore defy traditional assessment. We have a tough environment for these companies to make strategic, operational, or tactical decisions.

Impact on Individual Insurance
It was never in doubt that the ACA would require cancellation of most policies in the individual health insurance market. It was also known that consumers would face a very different health insurance world under the ACA, with some people seeing their premiums go down and some seeing them go up, and the majority of Americans seeing higher deductibles, higher copays, and a smaller pool of providers. We also knew that the exchanges and the ACA market rules would negate the need for state high-risk pools, meaning that most of these chronically ill consumers would see their policies ending in December 2013 or early in 2014.

It is puzzling why it took more than 3 years, the failed launch of the federal exchange, and the news media to start questioning the Obama Administration’s core approach to regulating existing health coverage. Whether you like or dislike the ACA policies, the 19.4 million Americans in various parts of the individual market deserved a heads-up.

Cost-Sharing and Premiums
The ACA requires people to buy a richer benefit package. It is possible to argue that this policy is good for society, but there is no free lunch, and this does eliminate choices that were acceptable to many consumers. Some can argue that federal premium subsidies in the exchange will more than absorb the higher costs of the ACA for moderate-income Americans, but that is just another way of saying, “Don’t worry, the taxpayer will pick up the tab for the cost of government regulations.”

Premiums, in and outside the exchanges, must be set using adjusted community rating, requiring the healthy, the young, and men to cross-subsidize the premiums of the unhealthy, the older, and women. Again, the foundation of the ACA is a collective redistribution intentionally creating winners and losers. You can argue the merits of this policy, but it does mean that many Americans will face vastly different premiums under the ACA.

The widely anticipated higher cost-sharing many people are now seeing in the exchanges is an inevitable byproduct of the ACA insurance market rules, the brave new actuarial risks of the post-ACA marketplace, and competition based on premiums and insurer brand names.

Medicaid Expansion
Medicaid covers approximately 74 million Americans today. As a result of Medicaid expansion under the ACA, including waiver-based expansions, the crowd-out effect, the streamlined eligibility and enrollment mandated by the ACA, and the normal growth of the program, Medicaid could conceivably reach between 95 million and 100 million enrollees by the year 2020. Although it is early, state data already indicate a surge in Medicaid enrollment.

Considering all the unknowns related to Medicaid expansion, including current and future economic conditions, it is safe to assume that the role of Medicaid in the US healthcare system, and the impact of Medicaid on federal and state budgets, will continue to grow.

Implementation Lessons
The Obama Administration, so enamored with the law and the law’s intentions and optics, grossly underestimated the push back from states and the sheer magnitude of the task. The administration’s painfully slow, opaque decision-making process hampered the state-run exchanges as well, and made life in state Medicaid agencies a nightmare. But the states, by experience and temperament, are typically far more adaptable and problem-solving oriented than the federal government. States with their own exchanges jumped in much earlier than CMS, making preliminary decisions, bringing on contractors, and pulling the pieces together as best they could.

Although unprecedented in its scope and complexity, the ACA as legislation deferred most of the decisions to federal agencies, especially CMS and the Internal Revenue Service. The law was also poorly written in key areas and poorly thought-out. Few laws are truly self-implementing, but virtually everything in the ACA, from a political, regulatory, or technical perspective, requires countless decisions and an astonishing amount of work before it is implemented.

Author Disclosure Statement
Mr Piper has no conflicts of interest to report.

Related Items
Pharmacy Integration
David B. Nash, MD, MBA
April 2019 Vol 12, No 2 published on April 17, 2019 in Editorial
A Global Quest for Reducing Harm in Patient Care
David B. Nash, MD, MBA
February 2019 Vol 12, No 1 published on February 6, 2019 in Editorial
Shut Off the Faucet and Stop Mopping the Floor
David B. Nash, MD, MBA
December 2018 Vol 11, No 9 published on December 27, 2018 in Editorial
Unscaling Population Health
David B. Nash, MD, MBA
November 2018 Vol 11, No 8 published on November 30, 2018 in Editorial
“Hoodoo” You Think Will Change?
David B. Nash, MD, MBA
October 2018 Vol 11, No 7 published on November 8, 2018 in Editorial
Last modified: January 13, 2014
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME